agilon health, inc. Deferred Foreign Income Tax Expense (Benefit)
agilon health, inc. (AGL) reported Deferred Foreign Income Tax Expense (Benefit) of -$384.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-25
- agilon health, inc. deferred foreign income tax expense (benefit) for fiscal 2025 was -$384.00K.
- agilon health, inc. deferred foreign income tax expense (benefit) for fiscal 2024 was -$142.00K.
- agilon health, inc. deferred foreign income tax expense (benefit) for fiscal 2023 was -$134.00K.
- agilon health, inc. deferred foreign income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$384.00K 10-K · filed 2026-02-25 |
| 2024-12-31 | -$142.00K 10-K · filed 2026-02-25 |
| 2023-12-31 | -$134.00K 10-K · filed 2026-02-25 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-25 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |